WHO ICTRP trial
Prevalence of somatic and germline mutations in patients with Primary or…
DRKS00030300 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00030300 |
|---|---|
| Public title | Prevalence of somatic and germline mutations in patients with Primary or relapsed endometrial carcinomas |
| Scientific title | Prevalence of somatic and germline mutations in patients with Primary or relapsed endometrial carcinomas - AGO-TR 2 |
| Primary sponsor | AGO Research GmbH, AGO Studiengruppe |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | C54.1;Endometrium;C54.1 |
| Interventions | Group 1: 200 patients with advanced stage (> T1 and/or N+) or recurrent carcinoma will be included. The aim of this prospective translational study is to investigate the prevalence of different germline and somatic gene mutations in… |
| Registration date | Mar 11, 2022 |
| Target size | 400 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: